Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/novel-first-class-drug-tied-improved-cognition-narcolepsy-2025a1000zxu?src=rss
Author :
Publish date : 2025-12-22 09:11:00
Copyright for syndicated content belongs to the linked Source.
